Reference values for kaolin-activated thromboelastography in healthy children

被引:110
作者
Chan, Kah-Lok
Summerhayes, Robyn G.
Ignjatovic, Vera [1 ]
Horton, Stephen B.
Monagle, Paul T.
机构
[1] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
[2] Royal Childrens Hosp, Dept Clin Hematol, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia
[4] Murdoch Univ, Childrens Res Inst, Murdoch, WA 6150, Australia
[5] Royal Childrens Hosp, Cardiac Surg Unit, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia
关键词
D O I
10.1213/01.ane.0000287645.26763.be
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: The hemostatic system of children changes with age and differs significantly from the hemostatic system of adults. Age-specific reference values are therefore required for most hemostatic variables. Thromboelastography(TEG (R)) is a point-of-care coagulation test that may provide superior evaluation and management of coagulopathies after cardiac surgery, when large-dose unfractionated heparin is administered for cardiopulmonary bypass. In this study, we established reference values for kaolin-activated TEG in healthy children, to facilitate accurate interpretation of pediatric TEG results. METHODS: Kaolin-activated TEG was performed on 100 healthy children undergoing elective day surgery and 25 healthy adult volunteers. The following TEG variables were recorded: reaction time, coagulation time, a angle, maximum amplitude, percentage lysis 30 min after maximum amplitude was reached, and the coagulation index. Differences between age-groups were evaluated using analysis of variance. RESULTS: Age-specific reference values for kaolin-activated TEG in healthy children between 1 mo and 16 yr of age are presented. No significant differences between children and adults were observed. CONCLUSIONS: TEG results, from a particular clinical setting, must be compared to age-specific, as well as analyzer- and activator-specific, reference values to allow for correct interpretation of the results. Reference values provided here will be of use in acute clinical situations where a practical monitor of hemostasis is required.
引用
收藏
页码:1610 / 1613
页数:4
相关论文
共 17 条
[1]  
ANDREW M, 1988, BLOOD, V72, P1651
[2]   DEVELOPMENT OF THE HUMAN COAGULATION SYSTEM IN THE FULL-TERM INFANT [J].
ANDREW, M ;
PAES, B ;
MILNER, R ;
JOHNSTON, M ;
MITCHELL, L ;
TOLLEFSEN, DM ;
POWERS, P .
BLOOD, 1987, 70 (01) :165-172
[3]  
ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95
[4]   MATURATION OF THE HEMOSTATIC SYSTEM DURING CHILDHOOD [J].
ANDREW, M ;
VEGH, P ;
JOHNSTON, M ;
BOWKER, J ;
OFOSU, F ;
MITCHELL, L .
BLOOD, 1992, 80 (08) :1998-2005
[5]   The effects of aprotinin on thromboelastography with three different activators [J].
Avidan, MS ;
Da Fonseca, J ;
Parmar, K ;
Alcock, E ;
Ponte, J ;
Hunt, BJ .
ANESTHESIOLOGY, 2001, 95 (05) :1169-1174
[6]  
Davis Matthew C, 2006, J Extra Corpor Technol, V38, P165
[7]   Hemostatic changes in pediatric neurosurgical patients as evaluated by Thrombelastograph® [J].
Goobie, SM ;
Soriano, SG ;
Zurakowski, D ;
McGowan, FX ;
Rockoff, MA .
ANESTHESIA AND ANALGESIA, 2001, 93 (04) :887-892
[8]   Therapeutic range for unfractionated heparin therapy: age-related differences in response in children [J].
Ignjatovic, V. ;
Summerhayes, R. ;
Than, J. ;
Gan, A. ;
Monagle, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) :2280-2283
[9]   INTRAOPERATIVE COAGULATION CHANGES IN CHILDREN UNDERGOING LIVER-TRANSPLANTATION [J].
KANG, YG ;
BORLAND, LM ;
PICONE, J ;
MARTIN, LK .
ANESTHESIOLOGY, 1989, 71 (01) :44-47
[10]  
Male C, 1999, CLIN LAB MED, V19, P39